Search - tctmd.com

Displaying 1 - 20 of 61

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

News Daily News

Cannabis Use Doubles the Risk of CV Death: Meta-analysis

Caitlin E. Cox

June 23, 2025

News Daily News

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

Caitlin E. Cox

June 13, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Daily News

Having Twins Ups the Risk of CVD Over the Next Year

Caitlin E. Cox

February 06, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Daily News

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

Caitlin E. Cox

July 10, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Todd Neale

January 11, 2024

News Daily News

Reduced EF Evident in Some Elite Endurance Athletes

Michael O'Riordan

December 21, 2023

News Daily News

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Caitlin E. Cox

December 12, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

What’s Going to Be Hot at ESC Congress 2025?

Cannabis Use Doubles the Risk of CV Death: Meta-analysis

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Having Twins Ups the Risk of CVD Over the Next Year

January 2025 Dispatch for the CV Team

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

September 2024 Dispatch for the CV Team

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Reduced EF Evident in Some Elite Endurance Athletes

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content